Form 8-K - Current report:
SEC Accession No. 0001933414-25-000064
Filing Date
2025-05-22
Accepted
2025-05-22 16:14:54
Documents
12
Period of Report
2025-05-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mlys-20250522.htm   iXBRL 8-K 32031
  Complete submission text file 0001933414-25-000064.txt   154692

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20250522.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20250522_lab.xml EX-101.LAB 23449
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20250522_pre.xml EX-101.PRE 13589
14 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20250522_htm.xml XML 2929
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41614 | Film No.: 25977294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)